{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:26:30Z","timestamp":1788546390511,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24390276"],"award-info":[{"award-number":["24390276"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009667","name":"Kyorin University Faculty of Medicine","doi-asserted-by":"publisher","award":["JPMH23FC1038"],"award-info":[{"award-number":["JPMH23FC1038"]}],"id":[{"id":"10.13039\/100009667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 19K08755"],"award-info":[{"award-number":["JP 19K08755"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["ippan-081"],"award-info":[{"award-number":["ippan-081"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH20FC1035"],"award-info":[{"award-number":["JPMH20FC1035"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030735","name":"Kyorin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.alit.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:19:06Z","timestamp":1762877946000},"page":"207-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytokine profile-guided management of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS\/TEN): A management algorithm useful for guiding the selection of treatment options"],"prefix":"10.1016","volume":"75","author":[{"given":"Yoshiko","family":"Mizukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shiohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.09.005_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41586-024-08061-0","article-title":"Spatial proteomics identifies JAKi as treatment for a lethal skin disease","volume":"635","author":"Nordmann","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.alit.2025.09.005_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54180-7","article-title":"Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2025.09.005_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-024-00889-6","article-title":"Update on Stevens-Johnson Syndrome and toxic epidermal necrolysis: diagnosis and management","volume":"25","author":"Shah","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib4","article-title":"Updates in SJS\/TEN: collaboration, innovation, and community","volume":"10","author":"Marks","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.alit.2025.09.005_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centers","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"key":"10.1016\/j.alit.2025.09.005_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jdv.16685","article-title":"Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis","volume":"35","author":"Torres-Navarro","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2025.09.005_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaad.2020.08.122","article-title":"Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta-analysis","volume":"84","author":"Tsai","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamadermatol.2023.0035","article-title":"Evaluation of plasmapheresis vs immunoglobulin as first treatment after ineffective systemic corticosteroid therapy for patients with Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"159","author":"Miyamoto","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/all.15608","article-title":"Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: diverse effects on systemic inflammation","volume":"78","author":"Schmidt","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.005_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bjd\/ljae321","article-title":"Recent progress in Stevens-Johnson syndrome\/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment","volume":"192","author":"Hama","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaci.2008.06.013","article-title":"Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment","volume":"122","author":"Murata","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.09.005_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ACI.0000000000000180","article-title":"Monitoring the acute response in severe hypersensitivity reactions to drugs","volume":"15","author":"Shiohara","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.09.005_bib13","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.jaip.2019.05.002","article-title":"Galectin-7 as a potential biomarker of Stevens-Johnson syndrome\/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells","volume":"7","author":"Hama","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.09.005_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/1346-8138.12925","article-title":"Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"42","author":"Aihara","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib16","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.jaip.2023.07.001","article-title":"Development and validation of a novel Score to predict mortality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: CRISTEN","volume":"11","author":"Hama","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.09.005_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.597761","article-title":"The roles of immunoregulatory networks in severe drug hypersensitivity","volume":"12","author":"Hsu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2025.09.005_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1346-8138.2010.01154.x","article-title":"Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: is cytokine expression analysis useful in predicting its therapeutic efficacy?","volume":"38","author":"Narita","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-4362.1997.00192.x","article-title":"Plasmapheresis in toxic epidermal necrolysis","volume":"36","author":"Chaidemenos","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(99)70497-4","article-title":"Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis","volume":"40","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.09.005_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.alit.2025.09.005_bib22","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/s41598-024-53653-5","article-title":"Effectiveness of early treatment with plasma exchange in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Senda","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2025.09.005_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2025.09.005_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijid.2020.08.078","volume":"100","author":"Mizukawa","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.alit.2025.09.005_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/TP.0000000000000816","article-title":"Plasma IL-10 levels to guide antiviral prophylaxis prevention of late-onset cytomegalovirus disease, in high risk solid kidney and liver transplant recipients","volume":"100","author":"Limaye","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.alit.2025.09.005_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","article-title":"T cell pathology in skin inflammation","volume":"41","author":"Sabat","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.alit.2025.09.005_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.alit.2025.09.005_bib28","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/eji.1830241002","article-title":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones","volume":"24","author":"Kennedy","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.alit.2025.09.005_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.alit.2025.09.005_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaip.2022.01.038","article-title":"Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: a multicenter observational study","volume":"10","author":"Zhang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.09.005_bib31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302500111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302500111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:15:57Z","timestamp":1774664157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S132389302500111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S132389302500111X"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.09.005","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine profile-guided management of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS\/TEN): A management algorithm useful for guiding the selection of treatment options","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}